Consistent Performance, Patient Strategy Yield Solid Q2 Results: There’s No Place Like HOMB
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Supermicro raises Q1 FY2027 revenue outlook on AI demand
- Dow outperforms as Wall Street rises, healthcare stocks lead gains
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
Home Bancshares (HOMB) PT Raised to $28 at RBC Capital
July 19, 2024 6:28 AM EDTRBC Capital analyst Jon G. Arfstrom raised the price target on Home Bancshares (NYSE: HOMB) to $28.00 (from $27.00) while maintaining a Sector Perform rating.
The analyst comments "We are recapping 2Q results. This was a strong quarter with solid loan growth, margin expansion, controlled... More



